Estradiol (E 2 ) can act in the brain in a relatively fast manner (i.e., seconds to minutes) usually through signaling initiated at the cell membrane. Brain-derived E 2 has thus been considered as another type of neurotransmitter. Recent work found that behaviors indicative of male sexual motivation are activated by estrogenic metabolites of testosterone (T) in a fast manner, while sexual performance (copulatory behavior per se) is regulated by brain E 2 in a slower manner via nucleus-initiated actions. This functional division between these two types of action appears to generalize to other behavioral systems regulated by E 2 . We propose the dual action of estrogen hypothesis to explain this functional distinction between these two different modes of action.
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Neuroestrogens versus ovarian estrogens
Estrogens are steroid hormones that were initially isolated and characterized in the late 1920s by Adolf Butenandt (Nobel laureate for this discovery) and Edward A. Doisy [1] . They are present in all vertebrates and some invertebrates, and are traditionally considered to be the primary female sex hormone because they are produced by the ovary, released into the blood, and play a key role in the control of female reproduction. Estrogens are secreted in the developing ovarian follicles by aromatization of androgenic substrates that have been produced locally. Aromatization is a complex enzymatic reaction catalyzed by aromatase (also known as estrogen synthase or EC 1.14.14.1, the product of gene CYP19), an enzyme of the cytochrome P450 family. Aromatization of androgens includes three successive hydroxylations resulting in the elimination of one methyl group and acquisition of a fully saturated (aromatic) 'A' ring [2] . The main substrates of aromatization are the androgens T and androstenedione that are transformed by aromatase into 17b-estradiol (E 2 ) and estrone (E 1 ), respectively.
In the late 1960s a marked level of aromatase activity (AA) was discovered in the brain of mammalian species including humans [3] , and this finding was soon generalized to representative species in the major vertebrate classes (i.e., fish, reptiles, birds [4]). These claims were based on data from radioenzyme assays quantifying the transformation of radioactive T into radioactive E 2 that were later supplemented by the identification of the presence of the relevant mRNA (by PCR or in situ hybridization) and of the enzymatic protein (by immunohistochemistry or western blot). This finding of widespread brain aromatase opened an entirely new field of investigation that resulted over the years in the demonstration that estrogens produced in the brain (termed neuroestrogens), either by the aromatization of testicular T or via a series of enzymatic steps from the precursor of all steroids, cholesterol [5, 6] , play a decisive role in (i) the sexual differentiation of brain and behavior, and (ii) the activation of male sexual behavior in rodents and many other vertebrate species [7] . Thus the notion that estrogens should be considered a 'female' hormone is an over-simplification. Estrogens have important roles in males as well. During the past few decades it was discovered that estrogens additionally control a host of physiological and pathological traits ranging from bone formation, lipid metabolism, and brain plasticity and repair to tumor growth. They are now considered as pleiotropic signaling factors whose action extends well beyond the control of reproduction.
The dual control of estrogen synthesis Ovarian and brain estrogens have exactly the same chemical structure and are produced by the same enzyme, aromatase. Two fundamentally different controls of brain AA have been identified that operate in distinct timedomains. In the long term, steroids increase transcription of the aromatase gene, resulting in increased enzyme concentration and thus activity (genomic control). In a shorter timescale, post-translational modifications of the enzymatic protein drastically modify its activity within minutes without changing its concentration (post-translational control) (Box 1).
Fast versus slow actions of estrogens
As other steroid hormones, estrogens are classically considered to exert their biological effects by binding to their cognate nuclear receptors [i.e., estrogen receptor a (ERa) and estrogen receptor b (ERb)], which then act as ligandactivated transcription factors to regulate transcription of specific genes associated with an estrogen-responsive element (ERE) or other types of response elements (e.g., AP1, Sp1, NF-kB) [8] . These biological effects are thus mediated via transcription of genes, translation of corresponding mRNAs into proteins, and their integration into functional pathways; they take hours to days to develop.
As early as 1976 it was observed that in the brain estrogens exert, in addition to these relatively slow effects, electrophysiological effects with latencies of only a few seconds [9] . This discovery was at the origin of an entirely
